The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts.
Linge A, Patil S, Grosser M, Lohaus F, Gurtner K, Kemper M, Gudziol V, Haim D, Nowak A, Tinhofer I, Zips D, Guberina M, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Boeke S, Gani C, Jöhrens K, Baretton GB, Löck S, Baumann M, Krause M; DKTK-ROG.
Linge A, et al. Among authors: balermpas p.
Radiother Oncol. 2024 Feb;191:110055. doi: 10.1016/j.radonc.2023.110055. Epub 2023 Dec 16.
Radiother Oncol. 2024.
PMID: 38109944
Free article.